Disease-modifying effects of finerenone in CKM syndrome
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- ESC Congress 2024
Continuation or interruption of OAC during TAVI?
Dirk Jan van Ginkel, MD
- ESC Congress 2024
Effects of empagliflozin on cardiac remodeling post-MI
Jaclyn Carberry, MD
- ESC Congress 2024
Beneficial effects of MRAs in HF across the LVEF spectrum
Pardeep Jhund, MD, PhD
- ESC Congress 2024
Lp(a) in patients with recent CHD
Prof. Kausik Ray, MBChB, MD, MPhil